Fenoldopam administering during major surgical procedures may significantly reduce the incidence of nephropathy. Researchers announced their findings here December 12th at the clinical meeting of the American Society of Health-System Pharmacists.
The findings are important because fenoldopam assisted in renal preservation and produced overall in-hospital cost savings, said lead researcher Daniel E. Hilleman, of Creighton University Medical Center in Omaha, Nebraska, United States.
למאמר מתוך
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!